drugset / Trial / NCT00518726
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects
Non-randomizedSingle-groupOpen-labelPrevention
Summary
To evaluate the antibody response to each influenza vaccine antigen when administering a single dose to subjects aged \> 18 years
Timeline
- Start
- 2007-06
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008 | Vaccine | 15 ug | — |